Patent · US Active

Antiviral compounds

US9132129B2 · kind B2 · utility

0Cited by

7References

13Claims

0Family size

Assignee

Katholieke Universiteit Leuven · BE

Inventors

Patrick Chaltin · Zétrud-Lumay, BE
Frauke Christ · Heverlee, BE
Zeger Debyser · Heverlee, BE
Marc De Maeyer · Heverlee, BE
Arnaud Marchand · Leuven, BE
Damien Marchand · Kessel-Lo, BE
Arnout Voet · Zwevegem, BE

Key dates

Filing date	Nov 15, 2011
Grant date	Sep 15, 2015
Priority date	—
Expiry date	Jan 28, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (A), as further defined herein, having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. The invention further relates to the use of such compounds, optionally combined with one or more other drugs having antiviral activity, for the treatment of animals suffering from viral infections, in particular HIV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.